SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Cuts CRISPR Therapeutics Price Target to $70 From $75

Valid market news retained in the public archive without immediate LiveCast distribution.

CRSP

Related stories